Encephalopathy induced by levetiracetam added to valproate

被引:6
作者
Bauer, J. [1 ]
机构
[1] Bonn Univ Hosp, Dept Epileptol, D-53105 Bonn, Germany
来源
ACTA NEUROLOGICA SCANDINAVICA | 2008年 / 117卷 / 05期
关键词
epilepsy; valproate; levetiracetam; encephalopathy;
D O I
10.1111/j.1600-0404.2007.00974.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background We report on the manifestation of a levetiracetam (LEV)-induced encephalopathy. Findings A 28-year-old man suffering from idiopathic epilepsy with generalized seizures was treated with LEV (3000 mg) added to valproate (VPA) (2000 mg). Frequency of generalized tonic-clonic seizures increased from one per 6 months to two per month. Neuropsychological testing showed impaired word fluency, psychomotor speed and working memory. The interictal electroencephalogram (EEG) showed a generalized slowing to 5 per second theta rhythms with bilateral generalized high-amplitude discharges. Outcome Following discontinuation of LEV, EEG and neuropsychological findings improved and seizure frequency decreased.
引用
收藏
页码:374 / 376
页数:3
相关论文
共 7 条
[1]   VALPROATE-ASSOCIATED ENCEPHALOPATHY [J].
BAUER, J ;
ELGER, CE .
AKTUELLE NEUROLOGIE, 1993, 20 (01) :16-21
[2]   Seizure-inducing effects of antiepileptic drugs: A review [J].
Bauer, J .
ACTA NEUROLOGICA SCANDINAVICA, 1996, 94 (06) :367-377
[3]   Valproate-induced hyperammonemic encephalopathy in the presence of topiramate [J].
Hamer, HM ;
Knake, S ;
Schomburg, U ;
Rosenow, F .
NEUROLOGY, 2000, 54 (01) :230-232
[4]   Serum concentrations of levetiracetam in epileptic patients:: The influence of dose and co-medication [J].
May, TW ;
Rambeck, B ;
Jürgens, U .
THERAPEUTIC DRUG MONITORING, 2003, 25 (06) :690-699
[5]   VALPROATE-ASSOCIATED ENCEPHALOPATHY [J].
PAKALNIS, A ;
DRAKE, ME ;
DENIO, L .
JOURNAL OF EPILEPSY, 1989, 2 (01) :41-44
[6]  
Rangel R, 1988, J EPILEPSY, V1, P197
[7]  
SACKELLARES J, 1979, EPILEPSIA, V20, P679